AMN Healthcare Services (AMN) Expected to Announce Earnings on Thursday

Key Points

• AMN Healthcare Services is expected to report Q3 2026 results after Thursday’s market close. Analysts forecast earnings of $0.23 per share and revenue of approximately $649.6 million.
• In the prior quarter, AMN reported adjusted earnings of $0.77 per share and revenue of $673.2 million, substantially exceeding analyst estimates; revenue rose 2.3% year over year.
• Analyst sentiment is moderately positive, with four Buy and four Hold ratings and a consensus price target of $36.50. The stock recently traded at $46.64, near its 12-month high of $49.62.

AMN Healthcare Services (NYSE:AMN - Get Free Report) is expected to be announcing its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect the company to post earnings of $0.2292 per share and revenue of $649.55 million for the quarter. Parties may review the information on the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.

AMN Healthcare Services (NYSE:AMN - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.19 by $0.58. The firm had revenue of $673.24 million during the quarter, compared to analyst estimates of $628.39 million. AMN Healthcare Services had a net margin of 3.06% and a return on equity of 19.92%. The business's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.30 EPS. On average, analysts expect AMN Healthcare Services to post $3.32 EPS for the current fiscal year and $1.11 EPS for the next fiscal year.

AMN Healthcare Services Stock Performance

AMN opened at $46.64 on Thursday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.00. The company has a market cap of $1.81 billion, a price-to-earnings ratio of 17.40, a PEG ratio of 1.65 and a beta of 0.40. The company's 50 day moving average is $36.72 and its 200 day moving average is $28.11. AMN Healthcare Services has a 12-month low of $14.97 and a 12-month high of $49.62.

Analyst Upgrades and Downgrades

A number of analysts have commented on AMN shares. UBS Group upped their target price on shares of AMN Healthcare Services from $32.00 to $35.00 and gave the company a "neutral" rating in a report on Friday, August 7th. Truist Financial lifted their price target on shares of AMN Healthcare Services from $26.00 to $40.00 and gave the stock a "buy" rating in a research note on Wednesday, July 22nd. Wall Street Zen downgraded shares of AMN Healthcare Services from a "buy" rating to a "hold" rating in a research report on Tuesday, August 25th. Citigroup restated an "outperform" rating on shares of AMN Healthcare Services in a research note on Friday, August 14th. Finally, BMO Capital Markets raised their target price on AMN Healthcare Services from $40.00 to $43.00 and gave the stock an "outperform" rating in a report on Friday, October 9th. Four research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, AMN Healthcare Services presently has an average rating of "Moderate Buy" and a consensus price target of $36.50.

About AMN Healthcare Services

AMN Healthcare Services, Inc is a healthcare workforce solutions and technology company that helps hospitals, health systems, medical practices and other healthcare organizations recruit, deploy and manage clinical and nonclinical personnel. The company operates through a portfolio of staffing, workforce management and language-services businesses.

Its services include temporary and permanent placement of registered nurses, allied healthcare professionals and physicians, as well as locum tenens staffing for doctors and advanced practice professionals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.